Metabolism - Clinical and Experimental
Volume 46, Issue 8 , Pages 862-871, August 1997

Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: Relationship to gender, pubertal development, growth, insulin, and nutritional status

  • Adriano Falorni

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Adriano Falorni, MD, Institute of Pediatrics, University of Perugia, Hospital S. Maria, 05100 Terni, Italy.
    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy
  • ,
  • Vittorio Bini

      Affiliations

    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy
  • ,
  • Gabriele Cabiati

      Affiliations

    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy
  • ,
  • Francesco Papi

      Affiliations

    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy
  • ,
  • Sergio Arzano

      Affiliations

    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy
  • ,
  • Federica Celi

      Affiliations

    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy
  • ,
  • Massimo Sanasi

      Affiliations

    • Pediatric Clinic, University of Perugia, Terni Italy
    • Nuclear Medicine Service, Hospital S. Maria, Terni, Italy

Received 8 July 1996; accepted 14 February 1997.

Abstract 

We measured fasting serum levels of type I procollagen C-terminal propeptide (PICP), insulin-like growth factor-I (IGF-I), and IGF binding protein-3 (IGFBP-3) in obese children and adolescents (obese subjects [OS]) to evaluate their relationship to growth, gender, pubertal stage, and weight excess (WE). The influence of insulin, growth hormone (GH), and weight loss was also studied. The study population consisted of 244 OS and 236 normal-weight subjects (NWS) matched for age, gender, and pubertal stage. At stage I, OS had a higher standard deviation score (SDS) for height than NWS of both genders. During the prepubertal phase, growth velocity (GV) was greater in OS than in NWS of both genders, but it was lower in female OS at stage II and male OS at stage III. PICP increased in puberty, with a more rapid decrease later in female OS and NWS; prepubertal values were higher in OS but were reduced at pubertal stage IV to V in comparison to NWS. Stepwise multiple regression analysis demonstrated that GV was the only anthropological variable correlating with PICP. IGF-I serum values increased significantly in puberty and were higher in OS than in NWS at stage I for both genders. IGFBP-3 values of OS exceeded those of NWS at stages I to III in males and I to II in females. No difference was observed for males versus females in each group, nor was any difference observed for the molar ratio between the two groups. Using stepwise analysis, a positive correlation between IGF-I and IGFBP-3 was observed in prepubertal but not in pubertal NWS. Fasting insulin values correlated with IGFBP-3 in OS, accounting for 24.8% of the variation in prepubertal subjects and 17.1% in pubertal subjects. No such correlation was observed in NWS. In prepubertal NWS, PICP and SDS of body mass index (BMI) correlated with IGF-I, accounting for 12.9% of the variation, and SDS of BNII correlated with IGFBP-3, explaining 27.8% of the variation. In prepubertal OS, no such correlations could be observed, but PICP and SDS of BMI accounted for 14.3% of the variation in the molar ratio. A significant reduction of IGFBP-3 and an increase of the molar ratio were detected after weight loss in 40 OS. In conclusion, we demonstrated that IGF-I and IGFBP-3 are influenced by age, gender, sexual development, and nutritional status. Also, an influence of insulin on IGFBP-3 serum levels was observed in OS. The relations of IGF-I to PICP in NWS and of the molar ratio to PICP in OS support the concept of IGF-I influence on skeletal growth. The increased IGFBP-3 serum values in OS suggest a possible role in controlling the growth stimulus induced by nutritional status.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by Novo Nordisk Farmaceutici.

PII: S0026-0495(97)90071-8

Metabolism - Clinical and Experimental
Volume 46, Issue 8 , Pages 862-871, August 1997